personalized medicine

Eduardo Vilar-Sanchez, MD, PhD: Genomics of Cancer and Personalized Medicine
Dec
19
2012

The Group Room at the 2012 European Society for Medical Oncology (ESMO) Congress in Vienna was made possible, in part, by: VIDEO TRANSCRIPT Selma Schimmel, Founder & CEO, Vital Options International This is Selma Schimmel for The Group Room at the ESMO 2012 Congress happening now in Vienna.  We are joined by Dr. Eduardo Vilar [...]

Read More
Advocacy in Action ESMO 2012: Cancer and the Media
Dec
18
2012

Selma Schimmel (Vital Options International), Kathy Redmond (Editor, Cancer World Magazine), Jola Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the media and cancer reporting. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the [...]

Read More
Advocacy in Action ESMO 2012: Advocate Perspectives in Tissue Collection and Research
Dec
18
2012

Selma Schimmel (Vital Options International), Kathy Oliver (International Brain Tumor Alliance), Francesco De Lorenzo (European Cancer Patient Coalition), Jola Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss tissue collection in cancer research. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, [...]

Read More
Advocacy in Action ESMO 2012: Personalized Medicine and Pathology
Dec
18
2012

Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy), Selma Schimmel (Vital Options International) and Stefania Vallone (Women Against Lung Cancer Europe – WALCE) discuss pathology and personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders [...]

Read More
Advocacy in Action ESMO 2012: The Challenges Of Genetic Marker Testing Requirements
Dec
18
2012

Kathy Oliver (International Brain Tumor Alliance), Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the challenges of the genetic marker testing requirements for patients. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in [...]

Read More
Advocacy in Action ESMO 2012: What Is the Future Of Personalized Cancer Medicine In Europe?
Dec
18
2012

Ian Banks (Chair of the ECCO Patient Advisory Committee) talks about the futire of personalized cancer medicine in Europe. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, its [...]

Read More
Advocacy in Action ESMO 2012: Key Policy Issues In Personalized Medicine
Dec
18
2012

Francesco De Lorenzo (European Cancer Patient Coalition) talks about the key policy issues around personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, its relevance for patients, [...]

Read More
Advocacy in Action ESMO 2012: Personalized Medicine and Patient Education
Dec
18
2012

Lorenz Jost (Chair, ESMO Patient Working Group) talks about personalized medicine and the importance of educating patients on the topic. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, [...]

Read More
Advocacy in Action ESMO 2012: What Is Personalized Medicine?
Dec
18
2012

Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) introduces personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, its relevance for patients, future research perspectives, collection of  [...]

Read More
Personalized Medicine and Cancer
Oct
29
2011

    This is the first in a three-part series on personalized medicine and cancer and how it may help doctors make important treatment decisions. The discussion highlights the advances in science that are changing what we know about cancer. The Group Room host, Selma Schimmel, sits down with Dr. Jonathan Goldman. Dr. Goldman is [...]

Read More